The aims of this brochure are to provide the reader with a simple introduction to genes and genetic processes in humans and an insight as to how this rapidly developing field of science could impact on the insurance i
The aims of this brochure are to provide the reader with a simple introduction to genes and genetic processes in humans and an insight as to how this rapidly developing field of science could impact on the insurance i
SCOR's results for the first nine months of 2013.
SCOR delivers a strong performance for the first nine months of 2013, recording net income of EUR 302 million.
SCOR delivers a strong performance for the first nine months of 2013, recording net income of EUR 302 million.
SCOR delivers a strong performance for the first nine months of 2013, recording net income of EUR 302 million
SCOR finalises the acquisition of 100% of Generali U.S. Holdings, Inc. (“Generali U.S.”), the holding company of Generali's U.S. life reinsurance operations, with effect from today.
